Daisuke Kurita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daisuke Kurita has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Azusa Tanaka
Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
75 shared publications - Hiroaki Miyoshi
Department of Pathology Kurume University School of Medicine Kurume Japan
75 shared publications - Jun-Ichirou Yasunaga
Department of Hematology, Rheumatology and Infectious Diseases Kumamoto University Hospital Kumamoto Japan
75 shared publications - Kazutaka Nakashima
Division of Pathology, Kurume University, Kurume, Japan
75 shared publications - Kenichi Tsujita
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University , Kumamoto
75 shared publications - Koichi Ohshima
Department of Pathology, Kurume University School of Medicine, Kurume, Japan
75 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Human cluster 2 genes whose H3K27me3 in TSS's was decreased.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Human cluster 2 genes whose H3K27me3 in TSS's was decreased.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Oligonucleotides used in this study.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Oligonucleotides used in this study.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Regulation of TP73 by BATF3 and IRF4.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Regulation of TP73 by BATF3 and IRF4.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Efficacy of the MCT1/4 inhibitor syrosingopine on ATL cells.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Efficacy of the MCT1/4 inhibitor syrosingopine on ATL cells.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Experimental reagents and resources with identifiers used in this study.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Experimental reagents and resources with identifiers used in this study.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Transcriptional regulation of SLC16A1 and SLC16A3 by TAp73, and mRNA expression levels of MCT-coding genes among various cancers.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Transcriptional regulation of SLC16A1 and SLC16A3 by TAp73, and mRNA expression levels of MCT-coding genes among various cancers.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Transcriptional regulation by HBZ protein and RNA and the status of TP73 expression.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Transcriptional regulation by HBZ protein and RNA and the status of TP73 expression.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Mouse cluster 2 genes whose H3K27me3 in TSS's was decreased.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
Mouse cluster 2 genes whose H3K27me3 in TSS's was decreased.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
TAp73 significance in HBZ pathogenesis and its effect on cellular metabolism.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
TAp73 significance in HBZ pathogenesis and its effect on cellular metabolism.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
HBZ protein alters epigenetic regulation of TAp73 by EZH2.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
HBZ protein alters epigenetic regulation of TAp73 by EZH2.